Iterum Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $2,620 |
Gross Profit | -8 | -7 | 2,180 | |
EBITDA | -5,360 | -4,387 | -6,559 | -11,375 |
EBIT | -5,368 | -4,395 | -6,566 | -11,815 |
Net Income | -6,094 | -4,997 | -7,101 | -12,362 |
Net Change In Cash | 0 | 0 | 0 | 2,620 |
Free Cash Flow | -2,672 | -6,761 | -13,083 | -12,457 |
Cash | 13,406 | 4,976 | 7,389 | 6,071 |
Basic Shares | 20,044 | 16,552 | 15,432 | 13,180 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1,750 | -1,800 | -2,104 | -161 |
EBITDA | -34,580 | -39,972 | -83,202 | -36,005 |
EBIT | -36,330 | -41,772 | -85,306 | -36,166 |
Net Income | -38,371 | -44,434 | -91,564 | -52,006 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 9,936 | |||
Free Cash Flow | -39,343 | -18,535 | -15,903 | -54,539 |
Cash | 6,071 | 21,092 | 27,446 | 14,508 |
Basic Shares | 12,962 | 12,236 | 163,367 | 24,009 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.24 |
2024-06-30 | -$0.30 |
2024-03-31 | -$0.46 |
2023-12-31 | -$0.94 |
